Reported 45,219 shares, up 12,164 (36.8%) from the prior quarter.
Reported value 35.5%; share count 36.8% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2024-03-31 | 32877 |
| 2024-06-30 | 35151 |
| 2024-09-30 | 40272 |
| 2024-12-31 | 47119 |
| 2025-03-31 | 21988 |
| 2025-06-30 | 38940 |
| 2025-09-30 | 90291 |
| 2025-12-31 | 766381 |
| 2026-03-31 | 917277 |
| 2026-06-30 | 1242618 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Added | 45,219 | +12,164 (36.8%) | < 0.01% | $1,242,618 | 2026-08-13 | |
| Q1 2026 | Added | 33,055 | +10,521 (46.7%) | < 0.01% | $917,277 | 2026-05-15 | |
| Q4 2025 | Added | 22,534 | +19,007 (538.9%) | < 0.01% | $766,381 | 2026-02-13 | |
| Q3 2025 | Added | 3,527 | +1,378 (64.1%) | < 0.01% | $90,291 | 2025-11-14 | |
| Q2 2025 | Reduced | 2,149 | -151 (-6.6%) | < 0.01% | $38,940 | 2025-08-15 | |
| Q1 2025 | Reduced | 2,300 | -686 (-23.0%) | < 0.01% | $21,988 | 2025-05-15 | |
| Q4 2024 | Added | 2,986 | +326 (12.3%) | < 0.01% | $47,119 | 2025-02-14 | |
| Q3 2024 | Added | 2,660 | +98 (3.8%) | < 0.01% | $40,272 | 2024-11-14 | |
| Q2 2024 | Added | 2,562 | +90 (3.6%) | < 0.01% | $35,151 | 2024-08-14 | |
| Q1 2024 | New | 2,472 | +2,472 (0.0%) | < 0.01% | $32,877 | 2024-05-15 |
Who else reported the position
108 managers reported ASSEMBLY BIOSCIENCES INC for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| GILEAD SCIENCES INC | Added | 4,977,089 | +471,698 | 8.3% | $136,770,406 | 7 qtrs |
| FARALLON CAPITAL MANAGEMENT LLC | Added | 1,604,590 | +377,000 | 0.2% | $44,094,133 | 4 qtrs |
| Paradigm Biocapital Advisors LP | Added | 1,553,748 | +888,497 | 0.8% | $42,696,995 | 3 qtrs |
| COMMODORE CAPITAL LP | Added | 1,415,000 | +415,000 | 2.32% | $38,884,200 | 4 qtrs |
| RA CAPITAL MANAGEMENT L P | Unchanged | 1,020,410 | 0 | 0.24% | $28,040,867 | 4 qtrs |
| Jupiter Topco LLC | New | 849,309 | +849,309 | < 0.01% | $23,368,737 | 1 qtr |
| BlackRock Inc | Added | 766,819 | +564,076 | < 0.01% | $21,072,187 | 8 qtrs |
| Parkman Healthcare Partners LLC | Added | 721,181 | +309,954 | 2.03% | $19,818,054 | 4 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 558,942 | +68,495 | < 0.01% | $15,359,726 | 2 qtrs |
| Point72 Asset Management L P | Added | 460,593 | +116,488 | 0.01% | $12,657,096 | 4 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- August 13, 2026
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
- Sole
- 43,286
- Shared
- 0
- None
- 1,933
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.